Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs-Reference-Cited by-同舟云学术

Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs

Published:2020-08-08 Issue:10 Volume:55 Page:990-999
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Nakagawa Mina^ORCID,Nawa Nobutoshi,Takeichi Eiko,Shimizu Taro,Tsuchiya Jun,Sato Ayako,Miyoshi Masato,Kawai-Kitahata Fukiko,Murakawa Miyako,Nitta Sayuri,Itsui Yasuhiro,Azuma Seishin,Kakinuma Sei,Fujiwara Takeo,Watanabe Mamoru,Tanaka Yujiro,Asahina Yasuhiro,

Funder

Japan Agency for Medical Research and Development

Grant-in-Aid for Scientific Research

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

https://link.springer.com/content/pdf/10.1007/s00535-020-01715-6.pdf

Reference32 articles.

1. Stanaway JD, Flaxman AD, Naghavi M, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of disease study 2013. Lancet. 2016;388:1081–8.

2. Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J Hepatol. 2019;70:151–71.